These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7932517

  • 1. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
    Celis H, Lijnen P, Fagard R, Staessen J, Thijs L, Amery A.
    J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].
    Ferrari P, Weidmann P, Riesen WF, Martius F, Luban S, Pasotti E, Erne P, Fragiacomo C, Noseda G, Reutter F.
    Schweiz Med Wochenschr; 1993 Sep 18; 123(37):1736-41. PubMed ID: 8211024
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
    Beigel Y, Brook G, Eisenberg S, Fainaru M, Harats D, Levy Y, Rubinstein A, Skurnik Y.
    Isr J Med Sci; 1993 May 18; 29(5):272-7. PubMed ID: 8314685
    [Abstract] [Full Text] [Related]

  • 8. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
    Fortschr Med; 1994 Feb 20; 112(5):57-64. PubMed ID: 8163252
    [Abstract] [Full Text] [Related]

  • 9. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 20; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia.
    Fogari R, Marasi G, Vanasia A, Zoppi A, Lusardi P, Preti P.
    Int J Clin Pharmacol Ther; 1997 Feb 20; 35(2):61-4. PubMed ID: 9147709
    [Abstract] [Full Text] [Related]

  • 11. A controlled trial of pravastatin vs probucol in the treatment of primary hypercholesterolemia.
    Gómez-Pérez FJ, Bustamante F, Vergara A, Villaseñor J, Wong B, Rull JA.
    Rev Invest Clin; 1992 Feb 20; 44(1):53-61. PubMed ID: 1523350
    [Abstract] [Full Text] [Related]

  • 12. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 20; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 13. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.
    Int J Clin Pharmacol Res; 1999 Dec 20; 19(4):105-16. PubMed ID: 10939028
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of pravastatin on serum lipid levels in elderly patients with hypercholesterolemia.
    Morimoto S, Koh E, Fukuo K, Higaki J, Ikegami H, Miki T, Hata T, Ogihara T.
    Clin Ther; 1994 Dec 20; 16(5):793-803. PubMed ID: 7859238
    [Abstract] [Full Text] [Related]

  • 15. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems.
    Lijnen P, Celis H, Fagard R, Staessen J, Amery A.
    J Hypertens; 1994 Jan 20; 12(1):59-64. PubMed ID: 8157945
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of primary hypercholesterolemia with pravastatin. A placebo-controlled trial].
    Frederiksen SM, Larsen ML, Oxenbøll IB, Pindborg T, Haghfelt T.
    Ugeskr Laeger; 1993 Sep 06; 155(36):2794-9. PubMed ID: 8236548
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
    Napoli C, Lepore S, Ambrosio G, Chiariello M.
    Cardiologia; 1992 Nov 06; 37(11):761-8. PubMed ID: 1298545
    [Abstract] [Full Text] [Related]

  • 18. [An evaluation of the efficacy and safety of pravastatin in patients with primary hypercholesterolemia. A Brazilian open multicenter study].
    Giannini SD.
    Arq Bras Cardiol; 1992 Oct 06; 59(4):319-27. PubMed ID: 1341189
    [Abstract] [Full Text] [Related]

  • 19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 06; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M, Rohmer V, Farnier M, Issa-Sayegh M, Corda C, Sirugue I, Gerlinger C, Masseyeff-Elbaz MF.
    Diabetes Metab; 2000 May 06; 26(3):184-91. PubMed ID: 10880891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.